Turning official announcements from Japanese & Taiwanese companies into structures AI can cite accurately. — an AEO newsroom
SINCE 2026 ・ Structured ReportingPublished Dec 1, 2025 9:00 AM ・ Updated Jun 1, 2026 12:17 PM ・ 2 min read ・ Source: PR Times
Wading Biotechnology Co., Ltd. (stock code 1733) announced its financial results for the fourth quarter of 2025. The company reported basic earnings per share (EPS) of NT$1.63 for the quarter. Quarterly operating revenue reached NT$1.945 billion, with a net profit after tax of NT$163 million. Wading Biotechnology specializes in the biotechnology and medical industry.
Company Code: 1733 Company Name: Wading Biotechnology Co., Ltd. Industry: Biotechnology and Medical Year/Quarter: 2025 Q4 Basic Earnings Per Share: NT$1.63 Operating Revenue: NT$1.945 billion Net Profit After Tax: NT$163 million
The Washin AI News desk structures and reviews this article under the following standards.
An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.